You are here: Industry Insights > HIV

News List

Encouraging data for ViiV’s long-acting, two-drug HIV therapy pharmatimes
November 01, 2018
ViiV Healthcare has unveiled encouraging mid-stage data backing a long-acting formulation of its two-drug regimen cabotegravir and rilpivirine for the treatment of HIV...
GSK announces results of three year trial into long-lasting HIV injection pharmafile
October 31, 2018
GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the HIV Glasgow Drug Therapy meeting in Scotland.
Encouraging data for ViiV’s long-acting, two-drug HIV therapy pharmatimes
October 31, 2018
According to long-term data from the Phase II LATTE-2 trial, the injectable regimen - administered either every eight weeks or every four weeks - showed “high rates of virologic response....
Researchers launch Phase 1 trial of HIV vaccine pharmafile
October 19, 2018
Researchers working with the non-profit organisation the International AIDS Vaccine Initiative (IAVI) have announced the launch of a Phase I clinical trial, aiming to test a novel vaccine candidate for HIV.
IAVI Announces Clinical Trial of HIV Vaccine Candidate americanpharmaceuticalreview
October 12, 2018
The International AIDS Vaccine Initiative (IAVI) announces the start of a Phase I clinical trial (IAVI G001) to test a novel vaccine candidate designed to stimulate the immune system to initiate a first step in the generation of potent proteins, known as
IAVI Announces Clinical Trial of HIV Vaccine Candidate americanpharmaceuticalreview
October 10, 2018
The International AIDS Vaccine Initiative (IAVI) announces the start of a Phase I clinical trial (IAVI G001) to test a novel vaccine candidate designed to stimulate the immune system to initiate a first step in the generation of potent proteins...
In clinical trials, new antibody therapy controls HIV for months after treatment worldpharmanews
September 29, 2018
To remain healthy, people infected with HIV must therefore adhere to strict medication regimens, which typically involve ingesting pills every day for the rest of their lives.
Merck bags USFDA approval for 2 new HIV drugs biospectrumasia
September 29, 2018
Since the beginning of the epidemic, more than 70 million people have been infected with the HIV virus and about 35 million people have died of HIV
Aurobindo Pharma gets SA health authority nod for HIV drug biospectrumasia
September 29, 2018
The approval further strengthens Aurobindo's HIV product basket in South Africa, which has the potential to improve the lives of millions of patients, as per BSE filing.
Antibody combo controls HIV for months fiercebiotech
September 28, 2018
New clinical trials from Rockefeller University researchers suggest that a combination of two anti-HIV antibodies is capable of suppressing HIV for months.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 24 25 Next page